Daniil Gataulin
Stock Analyst at Chardan Capital
(0)
# 4852
Out of 5,269 analysts
70
Total ratings
19.61%
Success rate
-25.97%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Cognition Therapeuti... | Maintains: Buy | 11 11 | 0.47 | 2240.43% | 5 | Feb 26, 2025 | |
MeiraGTx Hldgs | Maintains: Buy | 36 36 | 6.96 | 417.24% | 3 | Feb 24, 2025 | |
Outlook Therapeutics | Maintains: Neutral | 3 3 | 1.5 | 100% | 8 | Feb 18, 2025 | |
Ocugen | Maintains: Buy | 6 6 | 0.64 | 837.5% | 9 | Feb 13, 2025 | |
EyePoint Pharmaceuti... | Maintains: Buy | 33 33 | 6.2 | 432.26% | 9 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 6 | 1.68 | 257.14% | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 28 | 19.76 | 41.7% | 4 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 64 64 | 8.98 | 612.69% | 3 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 52 52 | 6.37 | 716.33% | 8 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 0.89 | 574.16% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 4 40 | 4.78 | 736.82% | 5 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 220 220 | 2.94 | 7382.99% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 22 13 | n/a | n/a | 2 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Sep 28, 2022 |